S&P 500 Futures
(-0.20%) 5 136.75 points
Dow Jones Futures
(-0.16%) 38 498 points
Nasdaq Futures
(-0.14%) 17 879 points
Oil
(-0.39%) $82.31
Gas
(1.67%) $2.06
Gold
(-1.00%) $2 334.20
Silver
(-2.19%) $27.06
Platinum
(-0.78%) $954.00
USD/EUR
(0.27%) $0.935
USD/NOK
(0.47%) $11.03
USD/GBP
(0.23%) $0.798
USD/RUB
(-0.11%) $93.20

Actualizaciones en tiempo real para N4 Pharma PLC [N4P.L]

Bolsa: LSE Industria: Pharmaceuticals, Biotechnology & Life Sciences
Última actualización29 abr 2024 @ 09:45

3.23% £ 0.800

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 09:45):

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom...

Stats
Volumen de hoy 644 688
Volumen promedio 759 144
Capitalización de mercado 2.15M
EPS £0 ( 2024-04-03 )
Last Dividend £18.00 ( 1997-05-19 )
Next Dividend £0 ( N/A )
P/E -0.800
ATR14 £0.0350 (4.62%)

N4 Pharma PLC Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

N4 Pharma PLC Finanzas

Annual 2023
Ingresos: £1 953.00
Beneficio Bruto: £1 953.00 (100.00 %)
EPS: £-0.00520
FY 2023
Ingresos: £1 953.00
Beneficio Bruto: £1 953.00 (100.00 %)
EPS: £-0.00520
FY 2022
Ingresos: £0
Beneficio Bruto: £0 (0.00 %)
EPS: £-0.00550
FY 2021
Ingresos: £0.00
Beneficio Bruto: £0.00 (0.00 %)
EPS: £-0.00850

Financial Reports:

No articles found.

N4 Pharma PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

N4 Pharma PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend £16.00 1995-05-22
Last Dividend £18.00 1997-05-19
Next Dividend £0 N/A
Payout Date 1997-07-01
Next Payout Date N/A
# dividends 5 --
Total Paid Out £85.20 --
Avg. Dividend % Per Year 0.00% --
Score 1.05 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-10-21)
£0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.05
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
1995 £0 0.00%
1996 £0 0.00%
1997 £0 0.00%
1998 £0 0.00%
1999 £0 0.00%
2000 £0 0.00%
2001 £0 0.00%
2002 £0 0.00%
2003 £0 0.00%
2004 £0 0.00%
2005 £0 0.00%
2006 £0 0.00%
2007 £0 0.00%
2008 £0 0.00%
2009 £0 0.00%
2010 £0 0.00%
2011 £0 0.00%
2012 £0 0.00%
2013 £0 0.00%
2014 £0 0.00%
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £0 0.00%
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RHIM.L Dividend Knight 2023-08-24 Annually 7 3.49%
HAT.L Dividend Knight 2023-09-07 Semi-Annually 18 2.55%
ASL.L Dividend Knight 2023-08-03 Semi-Annually 34 1.34%
UKCM.L Dividend King 2023-08-17 Quarterly 18 2.99%
MIG5.L Dividend Knight 2023-06-22 Semi-Annually 24 4.45%
D4T4.L Dividend Knight 2023-07-20 Semi-Annually 27 1.32%
SEIT.L Dividend Knight 2023-09-14 Quarterly 6 3.23%
IBST.L Dividend Knight 2023-08-24 Annually 9 2.72%
BILN.L Dividend Knight 2023-06-08 Sporadic 29 1.95%
WSP.L Dividend Knight 2023-06-29 Semi-Annually 30 1.95%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-649.941.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.9951.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.9871.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM14.860.80010.008.00[1 - 3]
quickRatioTTM14.730.80010.008.00[0.8 - 2.5]
cashRatioTTM12.571.50010.0010.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM-0.004782.00-0.00159-0.00318[0 - 30]
freeCashFlowPerShareTTM-0.004782.00-0.00239-0.00478[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM1.0001.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM-729.441.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.001530.800-3.32-2.66[0.5 - 2]
Total Score-1.289

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.5451.000-0.2570[1 - 100]
returnOnEquityTTM-0.9872.50-7.76-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.004782.00-0.00159-0.00478[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.004782.00-0.00159-0.00318[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.8831.500-9.220[0.5 - 2]
operatingCashFlowSalesRatioTTM-619.101.000-10.000[0.1 - 0.5]
Total Score-3.03

N4 Pharma PLC

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico